Pregnancy Screening After IVF and PGT: Which Tests Are Still Needed?

IVF and ICSI describe how fertilisation occurred; they do not remove the possibility of maternal medical conditions, structural fetal differences or pregnancy complications. The obstetric team should know the embryo transfer date, whether the embryo was fresh or frozen, any donor involvement relevant to clinical history and relevant medicines. Routine prenatal plans must still be tailored to age, health, obstetric history and national/local care standards. A fertility-clinic discharge note should support this transition rather than leave the patient to reconstruct dates alone.

PGT-A analyses selected cells from an embryo for chromosome-number findings. It does not diagnose every genetic condition, and mosaicism or sampling limitations may affect interpretation. Non-invasive prenatal testing (NIPT) screens for certain chromosomal risks using pregnancy-derived DNA information, while ultrasound assesses anatomy and development. Neither an embryo test nor a prenatal screen is the same as a diagnostic test. Patients should ask which tests are available and indicated, and what a positive, negative or uncertain result would mean.

When PGT-M was performed for a known familial gene condition, the report relates to that defined target under the test’s protocol. It is not a broad certificate against all genetic or structural disorders. Genetic counselling should explain residual risk and whether confirmatory prenatal diagnosis is offered or recommended for the specific familial condition. Decisions about invasive testing belong to the patient after expert discussion of potential benefits and procedure-related risks. Avoid promising that a targeted embryo test eliminates all inherited disease concerns.

Early ultrasound may confirm pregnancy location and development when clinically indicated, while later examinations assess anatomy and other features at appropriate gestational stages. The fertility team’s early scans do not substitute for the obstetric anatomy assessment. Timing follows the obstetric protocol and individual clinical findings. Severe abdominal pain, faintness or heavy bleeding requires urgent assessment even if hCG readings appear reassuring. An online calculator cannot confirm pregnancy location, fetal wellbeing or anatomy.

Bring the IVF timeline, transfer date and embryo stage, medication list, relevant medical conditions and any PGT laboratory report. Ask the obstetrician whether a genetics referral is needed, what screening and diagnostic choices apply and which results will guide follow-up. Avoid paying for repeated non-standard tests without a clear clinical question. Good antenatal planning includes preventive health, medications and wellbeing as well as screening choices. Patients should be supported in declining optional testing after informed discussion.

HomeIVF describes a doctor-led fertility-care model that may reduce unnecessary clinic visits through remote review and coordination. Teleconsultations may help explain the IVF record and prepare the obstetric handover; selected home blood collection may be possible if locally available and appropriate. Necessary pregnancy scans, diagnostic procedures, egg retrieval, embryology and embryo transfer require clinical settings. A remote conversation must never delay urgent pregnancy assessment or replace a qualified obstetric review.

Ask your clinician to write down the working diagnosis, which evidence supports it, the treatment options discussed and what result would actually change the plan. Confirm whether both partners have been appropriately assessed, what tests are necessary rather than merely available, who reviews time-sensitive findings and what happens when a cycle does not go as hoped. Request a complete estimate of investigation, medication, monitoring, facility and laboratory charges. Decisions should be framed as informed choices under uncertainty rather than sales deadlines or promised success.

HomeIVF is a doctor-led, home-supported fertility-care model intended to reduce unnecessary clinic visits rather than replace clinical IVF. Depending on medical needs and confirmed local availability, teleconsultations, selected home blood collection and help administering prescribed injections may be possible. None is promised for every patient or location. Required ultrasounds and examinations, clinical IUI, sperm retrieval, egg retrieval, embryology and embryo transfer must take place in appropriate facilities. Home services must follow the treating clinician’s orders and the laboratory’s timing and quality requirements. A patient with urgent symptoms needs an appropriate emergency service, not an online appointment.